Rizatriptan benzoate and Vomiting aggravated - a phase IV clinical study of FDA data

Summary:

Vomiting aggravated is reported as a side effect among people who take Rizatriptan benzoate (rizatriptan benzoate), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Diclofenac, and have Asthma.

The phase IV clinical study analyzes which people have Vomiting aggravated when taking Rizatriptan benzoate. It is created by eHealthMe based on reports of 1,704 people who have side effects when taking Rizatriptan benzoate from the FDA, and is updated regularly.

What is Rizatriptan benzoate?

Rizatriptan benzoate has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,886 Rizatriptan benzoate users. Check the latest studies of Rizatriptan benzoate.

What is Vomiting aggravated?

Vomiting aggravated is found to be associated with 1,929 drugs and 731 conditions by eHealthMe. Check the latest studies of Vomiting aggravated.

On Jul, 09, 2026

1,704 people reported to have side effects when taking Rizatriptan benzoate.
Among them, 137 people (8.04%) have Vomiting aggravated.

Could Rizatriptan benzoate cause Vomiting aggravated?

Among these 137 people:

How long have people been on Rizatriptan benzoate when they have Vomiting aggravated? *

Click here to view more results

What is the gender of people who have Vomiting aggravated when taking Rizatriptan benzoate? *

Click here to view

What is the age of people who have Vomiting aggravated when taking Rizatriptan benzoate? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Rizatriptan benzoate and have Vomiting aggravated?

- Check whether Vomiting aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rizatriptan benzoate:

Rizatriptan benzoate (1,886 reports)

Vomiting aggravated treatments and more:

Vomiting aggravated (33 reports)

How severe was Vomiting aggravated and when was it recovered:

Vomiting aggravated in Rizatriptan benzoate

Expand to all the drugs that have ingredients of rizatriptan benzoate:

Vomiting aggravated and drugs with ingredients of rizatriptan benzoate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rizatriptan benzoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vomiting aggravated:

Vomiting aggravated (1,929 drugs)

Browse all the conditions that are associated with Vomiting aggravated:

Vomiting aggravated (731 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rizatriptan benzoate (the active ingredients of Rizatriptan benzoate) and Rizatriptan benzoate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.